Joachim Tetteh Siaw
11 – 13 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2018
-
Mark
Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib
- Contribution to journal › Article
- 2017
-
Mark
Anaplastic lymphoma kinase L1198F and G1201E mutations identified in anaplastic thyroid cancer patients are not ligandindependent
- Contribution to journal › Article
- 2016
-
Mark
Brigatinib, an anaplastic lymphoma kinase inhibitor, abrogates activity and growth in ALK-positive neuroblastoma cells, Drosophila and mice
- Contribution to journal › Article
- « previous
- 1
- 2
- next »
